Analysis by the Quest Diagnostics Drug
Testing Index™ showed a positivity rate of only 0.02 percent in the general U.S. workforce in 2015 for our mystery drug, indicating its prevalence has severely diminished since its heyday. Yet, pockets of certain geographical areas throughout the U.S. such as Baltimore, Boston, Los Angeles, and New York City, continue to abuse this drug. Under federal law, this drug is classified as Schedule II and it remains one of five substances in the federally-mandated drug test panel. It’s legal use is restricted to veterinarians as a large-animal tranquilizer. Popular street names of the drug include the Angel Dust, PeaCe Pill, Rocket Fuel, Embalming Fluid, and Elephant
Tranquilizer, and it was originally filed under the trade name of Sernyl™. Tis month’s mystery drug is Phencyclidine, or PCP. ❚
Dr. Steven Sykes received his undergraduate degree in Biology from Morehouse College. Soon after, he pursued a doctorate at the University of Georgia in
both the Cellular Biology and Biochemistry Molecular Biology departments. Upon completion at UGA, he accepted a post- doctoral fellowship position with the Eukaryotic Pathogen Innovation Center at Clemson University in parasitology and later with Quest Diagnostics Employer Solutions focusing on workplace drug testing and prescription drug monitoring. Dr. Sykes currently serves as a
scientific director for Employer Solutions and is actively involved in forensic applications of analytical toxicology and consultation.
Nicole Jupe holds a bachelor’s degree from Baker University and a master’s degree from the University of Kansas. As a Marketing Manager at Quest Diagnostics, she is
responsible for brand awareness, content creation, website management, social media, and product marketing for laboratory-based testing products. She is also part of the team that publishes the Quest Diagnostics Drug Testing Index™. Nicole’s prior experience includes advertising, business-to-business marketing, corporate communications, and graphic design.
www.datia.org
datia focus
55
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
